Yuanda Wan, Liren Li, Ruilin Chen, Jiajia Han, Qiyun Lei, Zhipeng Chen, . . . Xingang Yao. (2024). Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo. Elsevier.
Chicago Style (17th ed.) CitationYuanda Wan, et al. Engineered Extracellular Vesicles Efficiently Deliver CRISPR-Cas9 Ribonucleoprotein (RNP) to Inhibit Herpes Simplex Virus1 Infection In vitro and In vivo. Elsevier, 2024.
MLA (9th ed.) CitationYuanda Wan, et al. Engineered Extracellular Vesicles Efficiently Deliver CRISPR-Cas9 Ribonucleoprotein (RNP) to Inhibit Herpes Simplex Virus1 Infection In vitro and In vivo. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.